P10276 (RARA_HUMAN) Homo sapiens (Human)
Retinoic acid receptor alpha UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
12 Experimental Structures
Description | PDB ID | Oligo-state | Range | Ligands | ||
---|---|---|---|---|---|---|
crystal structure of the RARalpha/RXRalpha ligand binding domain heterodimer in complex with a frag… |
Heteromer P28700; Q15788; | 1×LG2; 1×GOL; 1×EQN; | ||||
Assess | ||||||
Crystal structure of a mixed agonist-bound RAR-alpha and antagonist-bound RXR-alpha heterodimer lig… |
Heteromer P28700; Q15596; | 1×754; 1×REA; | ||||
Assess | ||||||
Crystal structure of RARalpha ligand binding domain in complex with a fragment of the TIF2 coactiva… |
Heteromer Q15596; | 2×EQN; 2×GOL; | ||||
Assess | ||||||
CRYSTAL STRUCTURE OF A HETERODIMERIC COMPLEX OF RAR AND RXR LIGAND-BINDING DOMAINS |
Heteromer P28700; | 1×OLA; 1×BMS; | ||||
Assess | ||||||
Crystal structure of RARalpha/RXRalpha ligand binding domain heterodimer in complex with BMS614 and… |
Heteromer P28700; | 1×OLA; 1×BMS; | ||||
Assess | ||||||
Crystal structure of RARalpha ligand binding domain in complex with an agonist ligand (Am580) and a… |
Heteromer Q15788; | 1×EQN; | ||||
Assess | ||||||
Retinoic acid receptor alpha mutant - N299H |
Heteromer Q15788; | 1×5Z6; | ||||
Assess | ||||||
Revealing a marine natural product as a novel agonist for retinoic acid receptors with a unique bin… |
Heteromer Q15788; | 1×LUF; | ||||
Assess | ||||||
Crystal structure of RARalpha ligand binding domain in complex with the inverse agonist BMS493 and … |
Heteromer O75376; | 2×EQO; 9×GOL; | ||||
Assess | ||||||
Crystal Structure of the Human RXR/RAR DNA-Binding Domain Heterodimer Bound to the Human RARb2 DR5 … |
Heteromer P19793; | 4×ZN; 1×GOL; 1×CL; | ||||
Assess | ||||||
STRUCTURE OF THE RXR/RAR DNA-BINDING DOMAIN HETERODIMER IN COMPLEX WITH THE RETINOIC ACID RESPONSE … |
Heteromer P19793; | 4×ZN; | ||||
Assess | ||||||
Crystal structure of the RAR alpha ligand-binding domain in complex with an antagonist | monomer | 1×6Q7; | ||||
Assess |
10 SWISS-MODEL models
Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
5uan.1.B | monomer | 0.80 | 2×ZN; | 84.05 | ||
Assess | ||||||
7wnh.2.A | monomer | 0.64 | 2×ZN; | 33.74 | ||
Assess | ||||||
7wnh.4.A | monomer | 0.64 | 2×ZN; | 33.74 | ||
Assess | ||||||
4nqa.1.A | monomer | 0.62 | 2×ZN; | 32.52 | ||
Assess | ||||||
4iqr.2.A | monomer | 0.60 | 2×ZN; | 28.93 | ||
Assess | ||||||
5uan.1.A | monomer | 0.60 | 1×ZN; | 32.52 | ||
Assess | ||||||
4iqr.2.B | monomer | 0.59 | 2×ZN; | 28.93 | ||
Assess | ||||||
3dzy.1.A | monomer | 0.59 | 2×ZN; | 32.72 | ||
Assess | ||||||
7prv.1.B | monomer | 0.58 | 2×ZN; | 21.21 | ||
Assess | ||||||
7kw7.1.F | monomer | 0.57 | 21.21 | |||
Assess |
11 SWISS-MODEL models built on isoform sequence
Template | Isoform | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) |
---|---|---|---|---|---|---|
Isoform 2 | 5uan.1.B | monomer | 0.80 | 2×ZN; | 84.10 | |
Assess | ||||||
Isoform 2 | 7wnh.2.A | monomer | 0.64 | 2×ZN; | 33.74 | |
Assess | ||||||
Isoform 2 | 7wnh.4.A | monomer | 0.64 | 2×ZN; | 33.74 | |
Assess | ||||||
Isoform 2 | 4nqa.1.A | monomer | 0.62 | 2×ZN; | 32.42 | |
Assess | ||||||
Isoform 2 | 5uan.1.A | monomer | 0.61 | 1×ZN; | 32.42 | |
Assess | ||||||
Isoform 2 | 4iqr.2.A | monomer | 0.60 | 2×ZN; | 28.93 | |
Assess | ||||||
Isoform 2 | 4iqr.2.B | monomer | 0.59 | 2×ZN; | 28.93 | |
Assess | ||||||
Isoform 2 | 3dzy.1.A | monomer | 0.59 | 2×ZN; | 32.62 | |
Assess | ||||||
Isoform 2 | 7prv.1.B | monomer | 0.57 | 2×ZN; | 21.28 | |
Assess | ||||||
Isoform 2 | 7kw7.1.F | monomer | 0.57 | 21.28 | ||
Assess | ||||||
Isoform 3 | 3a9e.1.B | monomer | 0.87 | 1×REA; | 98.88 | |
Assess |